Journal of Hepatology
Volume 44, Issue 1 , Pages 32-38 , January 2006

Should we screen for colorectal cancer in liver transplantation?

References 

  1. Organ Procurement and Transplantation Network (OPTN). US transplantations 1988–2004: http://www.optn.org/latestData/rptData.asp, accessed 07/19/2005.
  2. Sanchez W, Talwalkar JA, Gores GJ. “Will all liver transplant patients eventually die from cancer?”. J Hepatol 2006;44:13–18.
  3. Aucejo F, Rofaiel G, Miller C. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? J Hepatol 2006;44:19–23.
  4. Dufour JF, Fey MF. What is the current treatment of PTLD after liver transplantation? J Hepatol 2006;44:23–26.
  5. Euvrard S, Kanitakis J. Skin cancers after liver transplantation: What to do? J Hepatol 2006;44:27–32.
  6. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 2001;7:S109–S118
  7. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg. 1996;2:52–59
  8. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer. 1998;83:1237–1243
  9. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997;44:1172–1181
  10. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation. 1998;66:1193–1200
  11. Catena F, Nardo B. De novo malignancies after organ transplantation. Transplant Proc. 2001;33:1858–1859
  12. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol. 2001;34:84–91
  13. Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, Marcoval J, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl. 2001;7:971–975
  14. Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg. 1998;176:265–269
  15. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation. 2003;75:1983–1988
  16. Fleiss J. Statistical methods for rates and proportions. New York: Wiley; 1981;p. 33, see also p. 260–80
  17. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332:924–933
  18. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990;31:800–806
  19. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH, Greenstein AJ. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut. 1991;32:167–169
  20. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–1233
  21. Loftus EV, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology. 1998;27:685–690
  22. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–913
  23. Stewart T, Henderson R, Grayson H, Opelz G. Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res. 1997;3:51–55
  24. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer. 1995;60:183–189
  25. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25:1383–1384
  26. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89:1221–1227
  27. Hennekens CHBJ. Epidemiology in medicine. In:  SL M editors. Boston/Toronto: Little, Brown and Company; 1987;p. 82–85
  28. Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999;94:895–899
  29. Weller DA, DeGuide JJ, Riegler JL. Utility of endoscopic evaluations in liver transplant candidates. Am J Gastroenterol. 1998;93:1346–1350
  30. Rabinovitz M, Schade RR, Dindzans VJ, Belle SH, Van Thiel DH, Gavaler JS. Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology. 1990;99:195–199
  31. Singer LG, Weinacker AB, Levin L, Doyle RL, Theodore J. Diagnostic yield of screening colonoscopies in lung transplant candidates. Transplantation. 2001;72:530–532
  32. Parikshak M, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum. 2002;45:1655–1660
  33. Brunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: the EDTA-ERA registry experience. European dialysis and transplantation association-european renal association. Nephrol Dial Transpl. 1995;10(suppl 1):74–80
  34. US Vital Statistics. US age-specific mortality statistics: http://www.cdc.gov/nchs/data/dvs/mortfinal2002_work23r.pdf; 08/22/2005.
  35. Organ Procurement and Transplantation Network (OPTN). Survival after liver transplantation: http://www.optn.org/latestData/rptStrat.asp; 08/22/05.
  36. Organ Procurement and Transplantation Network (OPTN). Liver transplantations by cause: http://www.optn.org/latestData/rptData.asp; 08/25/2005.
  37. Itzkowitz SH, Daniel H, for the Crohn's Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314–321.

PII: S0168-8278(05)00677-X

doi: 10.1016/j.jhep.2005.10.011

Journal of Hepatology
Volume 44, Issue 1 , Pages 32-38 , January 2006

Article Tools

* Image Usage & Resolution